Meet with Predicine at SITC 2018
November 7-11, 2018 | Washington D.C
Predicine will be attending and exhibiting at the upcoming Society for Immunotherapy of Cancer’s 33rd Annual Meeting (SITC 2018) at the Walter E. Washington Convention Center in Washington, D.C.
Meet with us to discover how ctRNA + ctDNA liquid biopsy technology revolutionize and personalize how cancer patients are diagnosed and treated. Our ctDNA+ctRNA combo liquid biopsy test provides a comprehensive understanding of the molecular alterations in cancer. We partners with leading biopharma companies and hospitals to support global clinical trials, early cancer screening, and targeted therapy.
Submit your information below to set up a one-on-one meeting with us!
Booth # 210
Onsite Poster Presentation
Detection and validation of cancer immunotherapy biomarkers in blood and urine-based liquid biopsy
Abstract Poster #: P28
Poster Hall Location: Hall E
Category: Biomarkers and Immune Monitoring
Date: Saturday, Nov. 10
Time: 12:20 – 1:50 p.m. and 7:00 – 8:30 p.m.